Amgen gains on elevated guidance

Amgen Inc. (NASDAQ:AMGN) gained $3.06 to $171.69 in early after hours trading on Thursday after raising its 2015 guidance and reporting 2Q15 earnings. The company now estimates $21.1-$21.4 billion in revenues, up from $20.9-$21.3 billion; and an adjusted EPS of $9.55-$9.80, up from $9.35-$9.65.

Amgen reported revenues of $5.4 billion, up 4% from $5.2 billion in 2Q14. Amgen said a 6% increase in product sales was offset partially by changes in foreign exchange rates. ...